# EDGAR Filing Document

**Accession Number:** 0001911010
**File Stem:** 0001104659-25-086378
**Filing Date:** 2025-9
**Character Count:** 8329
**Document Hash:** 9f767f4c798bc95d562e746fd4ad375b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-086378.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001104659-25-086378

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nextech Invest Ltd.
- **CENTRAL INDEX KEY:** 0001911010

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-22157
- **FILM NUMBER:** 251285696

**BUSINESS ADDRESS:**
- **STREET 1:** BAHNHOFSTRASSE 18
- **CITY:** ZURICH
- **STATE:** V8
- **ZIP:** CH-8001
- **BUSINESS PHONE:** 41 (0)44 366 66 11

**MAIL ADDRESS:**
- **STREET 1:** BAHNHOFSTRASSE 18
- **CITY:** ZURICH
- **STATE:** V8
- **ZIP:** CH-8001

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Nextech Invest AG
- **DATE OF NAME CHANGE:** 20220214

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001911010

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Nextech Invest Ltd.

**Address:** BAHNHOFSTRASSE 18, ZURICH, V8 CH-8001

**Telephone number:** 41-44-366-66-11

**Name of agent for service:** Marco Weibel

**Agent Address:** c/o Nextech Invest Ltd., Zurich, V8 CH-8001

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-22157

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER             | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   | SHARES VOTED FOR OR AGAINST MANAGEMENT   | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|:---|:---|:---|
| Arvinas, Inc.              | 04335A105 | 06/25/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Cullinan Oncology, Inc.    | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, to approve our named executive officer compensation.                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Cullinan Oncology, Inc.    | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Mersana Therapeutics, Inc. | 59045L106 | 06/12/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Relay Therapeutics Inc     | 75943R102 | 06/06/2025     | To consider and act upon an advisory vote on the compensation of our named executive officers.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Revolution Medicines, Inc. | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Silence Therapeutics Plc   | 82686Q101 | 06/26/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached proxy                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Silence Therapeutics Plc   | 82686Q101 | 06/26/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers - ONE YEAR                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Silence Therapeutics Plc   | 82686Q101 | 06/26/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers - TWO YEAR.                                                                                             | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Silence Therapeutics Plc   | 82686Q101 | 06/26/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers - THREE YEARS                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Tango Therapeutics, Inc.   | 87583X109 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Tango Therapeutics, Inc.   | 87583X109 | 06/05/2025     | Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers.                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Zymeworks, Inc.            | 98985Y108 | 12/10/2024     | Advisory Vote on the compensation of our named executive officers                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |

## N-PX: Signature Block

**Reporting Person:** Nextech Invest Ltd.

**By (Signature):** Marco Weibel

**By (Printed Signature):** Marco Weibel

**By (Title):** Chief Financial Officer

**Date:** 09/02/2025